
Gabon longs to cash in on sacred hallucinogenic remedy
Beneath yellow fruit, hidden within the roots of the iboga plant in the forests of Gabon, lies a sacred treasure that the country is keen to make the most of. For centuries, religious devotees have eaten it -- a psychotropic shrub that users say has addiction-fighting powers. It fascinates foreign visitors, psychiatric patients and rich pharmaceutical companies that want to market it. Now this central African country, where its use is enshrined in ancestral tradition, is scrambling to avoid missing out on the boom.
Teddy Van Bonda Ndong, 31, an initiate in the Bwiti spiritual tradition, calls it 'sacred wood'. He consumes it in small amounts daily, he said, for his 'mental and physical health'. 'It has a lot of power to help human beings,' added Stephen Windsor-Clive, a 68-year-old retiree. 'It's untapped. A mysterious force lies within this plant.' He travelled to Gabon from Britain and consumed iboga -- in a powder ground from its roots -- during a 10-day Bwiti ceremony. He tried it with a view to adopting it as a treatment for his daughter, who suffers from mental illness.
Economic potential
Given the interest, Gabon is seeking to channel the plant onto the international marketplace. Exports of iboga products, including its active ingredient ibogaine, are few and strictly regulated in the country. It grows mostly in the wild, but 'more and more effort is being made to domesticate the plant', said Florence Minko, an official in the forestry ministry. Potentially toxic in high doses, ibogaine can have effects similar to LSD, mescaline or amphetamines, and cause anxiety and hallucinations.
A general view of a jar filled with finely ground iboga powder displayed in Akanda.
An initiated member of Bwiti responds during an interview on their spiritual experience and the central role of iboga in Bwiti in Ndossy Village, Akanda.
A woman holds the Ghessandza, a traditional instrument, in Ndossy Village, Akanda.
A player of the moungongo, a traditional Gabonese harp, and a player of the Ngoma, a traditional drum, perform during the ceremony in Ndossy Village, Akanda.
An initiated participant extracts the iboga root in Ndossy Village, Akanda.
But users believe it can help drug addicts kick their habit and treat post-traumatic stress and neurological illnesses. Yoan Mboussou, a local microbiologist and Bwiti initiate, hopes to gain an export licence for the 500-milligram ibogaine capsules he produces at his laboratory near the capital Libreville.
He sells them in Gabon as a food supplement, declaring them to have 'anti-fatigue, antioxidant and anti-addictive' qualities. Iboga, he believes, 'is a potential lever to develop the economy and the whole country'.
Tradition and IP
Countries such as the United States and France class iboga as a narcotic because of health risks identified in studies, especially heart issues. But it is used in treatment centers in countries including the Netherlands, Mexico and Portugal. Numerous studies have examined its effects -- both helpful and harmful -- and scientists have taken out dozens of international patents for ibogaine therapeutic treatments.
'Most of those are based on studies of iboga use by Gabonese people, particularly by Bwiti practitioners,' said Yann Guignon, from the Gabonese conservation group Blessings Of The Forest. Despite the plant's 'colossal therapeutic benefits', 'Gabon is clearly missing out on the economic potential of iboga,' he added.
'It did not position itself in this market in time by developing productive iboga plantations, a national processing laboratory and a proper industrial policy.' Overseas laboratories meanwhile have worked out how to make synthetic ibogaine and to extract it from other plants, such as Voacanga africana. That flowering tree is available in greater quantities in Ghana and Mexico, which 'can produce ibogaine at unbeatable prices', said Guignon.
A man holds the freshly harvested iboga root and prepares to hand it to one of the initiated participants during the second stage of The Call of the Sacred Wood ceremony.
A woman peels the sacred root during the second stage of The Call of the Sacred Wood ceremony.
A man shows the iboga root after being carefully pounded into fine powder as part of the Sacred Call of the Sacred Wood ceremony.
A man consume the sacred powder from a tablespoon, following the transformation of the iboga root into powder as part of the ongoing Call of the Sacred Wood ceremony.
A man peels the iboga root during the Sacred Call of the Sacred Wood ceremony.
And 'Gabonese traditional knowledge is not protected by intellectual property regulations.' Currently only one company in Gabon has a licence to export iboga products -- though Minko, from the forestry ministry, said the country hopes this number will rise in the coming years. She said companies were likely to produce more, spurred by revenue guarantees under the Nagoya Protocol, an international agreement on biological diversity and resource-sharing.
She wants the country to obtain a 'made in Gabon' certificate of origin for iboga. 'This is a huge resource for Gabon. We have drawn up a national strategy for the conservation and sustainable use of the product,' she said. 'Gatherings will soon be organized, bringing together all the groups concerned: NGOs, traditional practitioners and scientists.'
Soothing properties
After harvesting iboga to the sound of traditional harps and consuming it in the initiation ceremony, Stephen Windsor-Clive was convinced by the benefits of iboga. 'I definitely want to bring my daughter here and have her have the experience,' he said. 'This is my last attempt to find something which might be of assistance to her.'
Another visitor, Tafara Kennedy Chinyere, travelled from Zimbabwe to discover Gabon and found, in the initiation, relief from anxiety and his 'inner demons'. 'I feel good in my body, in myself,' he said, sitting under a tree after the ceremony. 'I feel like the iboga helped me to let go of things that you no longer need in your life.' — AFP

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles

Kuwait Times
26-05-2025
- Kuwait Times
Gabon longs to cash in on sacred hallucinogenic remedy
Beneath yellow fruit, hidden within the roots of the iboga plant in the forests of Gabon, lies a sacred treasure that the country is keen to make the most of. For centuries, religious devotees have eaten it -- a psychotropic shrub that users say has addiction-fighting powers. It fascinates foreign visitors, psychiatric patients and rich pharmaceutical companies that want to market it. Now this central African country, where its use is enshrined in ancestral tradition, is scrambling to avoid missing out on the boom. Teddy Van Bonda Ndong, 31, an initiate in the Bwiti spiritual tradition, calls it 'sacred wood'. He consumes it in small amounts daily, he said, for his 'mental and physical health'. 'It has a lot of power to help human beings,' added Stephen Windsor-Clive, a 68-year-old retiree. 'It's untapped. A mysterious force lies within this plant.' He travelled to Gabon from Britain and consumed iboga -- in a powder ground from its roots -- during a 10-day Bwiti ceremony. He tried it with a view to adopting it as a treatment for his daughter, who suffers from mental illness. Economic potential Given the interest, Gabon is seeking to channel the plant onto the international marketplace. Exports of iboga products, including its active ingredient ibogaine, are few and strictly regulated in the country. It grows mostly in the wild, but 'more and more effort is being made to domesticate the plant', said Florence Minko, an official in the forestry ministry. Potentially toxic in high doses, ibogaine can have effects similar to LSD, mescaline or amphetamines, and cause anxiety and hallucinations. A general view of a jar filled with finely ground iboga powder displayed in Akanda. An initiated member of Bwiti responds during an interview on their spiritual experience and the central role of iboga in Bwiti in Ndossy Village, Akanda. A woman holds the Ghessandza, a traditional instrument, in Ndossy Village, Akanda. A player of the moungongo, a traditional Gabonese harp, and a player of the Ngoma, a traditional drum, perform during the ceremony in Ndossy Village, Akanda. An initiated participant extracts the iboga root in Ndossy Village, Akanda. But users believe it can help drug addicts kick their habit and treat post-traumatic stress and neurological illnesses. Yoan Mboussou, a local microbiologist and Bwiti initiate, hopes to gain an export licence for the 500-milligram ibogaine capsules he produces at his laboratory near the capital Libreville. He sells them in Gabon as a food supplement, declaring them to have 'anti-fatigue, antioxidant and anti-addictive' qualities. Iboga, he believes, 'is a potential lever to develop the economy and the whole country'. Tradition and IP Countries such as the United States and France class iboga as a narcotic because of health risks identified in studies, especially heart issues. But it is used in treatment centers in countries including the Netherlands, Mexico and Portugal. Numerous studies have examined its effects -- both helpful and harmful -- and scientists have taken out dozens of international patents for ibogaine therapeutic treatments. 'Most of those are based on studies of iboga use by Gabonese people, particularly by Bwiti practitioners,' said Yann Guignon, from the Gabonese conservation group Blessings Of The Forest. Despite the plant's 'colossal therapeutic benefits', 'Gabon is clearly missing out on the economic potential of iboga,' he added. 'It did not position itself in this market in time by developing productive iboga plantations, a national processing laboratory and a proper industrial policy.' Overseas laboratories meanwhile have worked out how to make synthetic ibogaine and to extract it from other plants, such as Voacanga africana. That flowering tree is available in greater quantities in Ghana and Mexico, which 'can produce ibogaine at unbeatable prices', said Guignon. A man holds the freshly harvested iboga root and prepares to hand it to one of the initiated participants during the second stage of The Call of the Sacred Wood ceremony. A woman peels the sacred root during the second stage of The Call of the Sacred Wood ceremony. A man shows the iboga root after being carefully pounded into fine powder as part of the Sacred Call of the Sacred Wood ceremony. A man consume the sacred powder from a tablespoon, following the transformation of the iboga root into powder as part of the ongoing Call of the Sacred Wood ceremony. A man peels the iboga root during the Sacred Call of the Sacred Wood ceremony. And 'Gabonese traditional knowledge is not protected by intellectual property regulations.' Currently only one company in Gabon has a licence to export iboga products -- though Minko, from the forestry ministry, said the country hopes this number will rise in the coming years. She said companies were likely to produce more, spurred by revenue guarantees under the Nagoya Protocol, an international agreement on biological diversity and resource-sharing. She wants the country to obtain a 'made in Gabon' certificate of origin for iboga. 'This is a huge resource for Gabon. We have drawn up a national strategy for the conservation and sustainable use of the product,' she said. 'Gatherings will soon be organized, bringing together all the groups concerned: NGOs, traditional practitioners and scientists.' Soothing properties After harvesting iboga to the sound of traditional harps and consuming it in the initiation ceremony, Stephen Windsor-Clive was convinced by the benefits of iboga. 'I definitely want to bring my daughter here and have her have the experience,' he said. 'This is my last attempt to find something which might be of assistance to her.' Another visitor, Tafara Kennedy Chinyere, travelled from Zimbabwe to discover Gabon and found, in the initiation, relief from anxiety and his 'inner demons'. 'I feel good in my body, in myself,' he said, sitting under a tree after the ceremony. 'I feel like the iboga helped me to let go of things that you no longer need in your life.' — AFP

Kuwait Times
21-05-2025
- Kuwait Times
Kenya's desperate need for more snake antivenom
Writhing in pain on a hospital bed in a Kenyan coastal town, teenage snakebite victim Shukurani Konde Tuva faced the grim reality of his left leg from above the knee being amputated. The 14-year-old was bitten by a puff adder -- a venomous snake and the most common snakebite in sub-Saharan Africa -- while eating outdoors in his village near the town of Malindi more than a month ago. His family rushed him to hospital two hours away by motorbike, but the antivenom he received did not help. "My son's leg is totally rotten and maggots are even emanating from it. They'll have to cut it," said his distraught mother, Mariamu Kenga Kalume. Some 5.4 million people are bitten by snakes each year globally and roughly half are poisoned by venom, according to World Health Organization (WHO) data. Up to 138,000 people die and 400,000 suffer permanent physical effects, though the WHO says the numbers are a "gross underestimation" since an estimated 70 percent of cases go unreported. Traditional beliefs and myths skew the data as some victims turn to home-grown remedies or attribute bites to voodoo "sent by their enemies" instead of seeking medical care. Wathuto Ogopotse prepares venom samples for analysis. Wathuto Ogopotse prepares venom samples for analysis. Wathuto Ogopotse analyses the progress of an SDS-Page test. Valentine Musabyimana analyses the result of an SDS-page test. Vials of desiccated snake venom from various species is stored in a cold storage space at the Kenya Snakebite Research and Intervention Centre. Head herpatologist, Geofrey Maranga, shows vials of desiccated snake venom from various species in cold storage. Head herpetologist, Geofrey Maranga, retrieves a black mamba from it's enclosure. Veterinary doctor, Allan Ragi (right) with assistant herpetologist, Morgan Kirwa (second right) assist Head Herpetologist, Geofrey Maranga (left partially concealed) moving cases holding various species of venomous snakes on a trolley into a room prepared for extraction of venom. Head herpetologist, Geofrey Maranga (right), is assisted to control an Egyptian Cobra during extraction of venom from various snake species. Head herpetologist, Geofrey Maranga, handles an African puff adder during an extraction of it's venom. Head herpetologist, Geofrey Maranga, handles a black mamba during an extraction of it's venom. 'Snake stone' A few kilometers (miles) from where Shukurani lay in pain, traditional healer Douglas Rama Bajila showed AFP the concoctions he uses to "suck out" venom. One popular remedy is the "snake stone", made from a cow's bone and sold for about $1. Bajila said it can be reused multiple times: it simply needs to be soaked in milk for a few hours to "recharge". One was placed on Shukurani's leg as he was transported to hospital but unfortunately fell off along the way, his mother said. Experts worry that by using traditional snakebite remedies, patients are losing precious time but they are popular because antivenom treatments are expensive. Antivenoms cost up to 8,000 shillings (about $62) per vial, and some patients require as many as 20 doses. Ruth Kintalel, 30, from a pastoralist community in Kajiado county near the capital Nairobi, said she spent over five months in hospital after a red spitting cobra bit her in her sleep. "My husband sold our livestock to cover the rising hospital bill," said Kintalel, who is still paralysed in her right arm seven years later. Head herpetologist, Geofrey Maranga (right), is assisted by Veterinary doctor, Allan Ragi (center) assistant herpetologist and Morgan Kirwa (left) to control a black mamba during extraction of it's venom. An African puff adder takes on a defensive posture in its enclosure at the Kenya Snakebite Research and Intervention Centre. A Jameson's mamba moves in its enclosure at the Kenya Snakebite Research and Intervention Centre. A black mamba moves in its enclosure at the Kenya Snakebite Research and Intervention Centre. Head herpetologist, Geofrey Maranga, gestures at a beaker containing venom from a puff adder. Head herpetologist, Geofrey Maranga, uses a pipette to collect droplets of venom on a membrane covering a beaker containing venom from a African Puff adder. Shukurani Konde Tuva (left), 14, sits on his hospital bed, suffering with necrosis to the tissue on his left-leg caused by the Cytotoxic venom from the bite of a Puff adder snake. Mary Mumbi (right), 31, returns an Ashe's Spitting Cobra into its box that she and her colleagues have just finished cleaning out at the Watamu Snake Farm in Watamu. A Boomslang, with potentially the most potent venom of all venomous species in Sub-Saharan Africa sits in its box at the Watamu Snake Farm. Villagers who have experienced one or more encounters with snakes in their home environments raise their hands during an education and awareness campaign conducted by snake handlers from the Watamu Snake Farm. 'Bad reactions' Experts say Kenya receives between 10,000 and 30,000 vials of antivenom per year and needs 100,000. Antivenom is made by "milking" venom from the fangs of snakes, which is then diluted and injected in small doses into animals such as horses, which produce antibodies that can be extracted for use in humans. Using snakes from different regions, even of the same species, can reduce the effectiveness of the antivenom and cause "really bad reactions", said Kyle Buster Ray, a curator at the Watamu Snake Farm on the Kenyan coast. Kenya's stock of antivenom is not always effective because much comes from other countries like India, he said. His farm houses over 400 venomous and non-venomous snakes and seeks to re-establish faith in antivenom that has been undermined by too many shoddy treatments. It offers free antivenom to critical cases locally, but stocks are limited. The farm also trains communities in life-saving snakebite responses. During a session attended by AFP, about half the community said they had been bitten at least once, and nearly all had initially turned to traditional medicines. Many showed signs of paralysis, with one suffering partial blindness. A villager who has experienced one or more encounters with snakes in their home environments reacts as she narrates the ordeal during an education and awareness campaign conducted by snake handlers. Villagers mill around wooden boxes containing venomous snakes to catch a glimpse of a Cobra during an education and awareness campaign conducted by snake handlers. Kyle Ray, the curator at Watamu Snake Farm, speaks during an interview at the farm as he cradles a Sand Boa snake in his hands. Kyle Ray, the curator at Watamu Snake Farm, holds a vial of antivenom during an interview at the farm in Watamu. Snake handlers give a demonstration to visitors on safe methods for containing venomous snakes in domestic environments at the Watamu Snake Farm in Watamu. Douglas Bajila, a traditional healer holds powder in his hand at his makeshift clinic, where he claims to treat venomous snake-bites using traditional medicine extracted from plant and snake derivatives. Douglas Bajila, a traditional healer stands at his makeshift clinic where he claims to treat venomous snake-bites using traditional medicine extracted from plant and snake derivatives in Malindi. Zakaria Muturi, 37, a puff adder bite survivor conducts an education and awareness campaign. Zakaria Muturi, 37, a puff adder bite survivor conducts an education and awareness campaign. Villagers react to the sight of a snake handled by Zakaria Muturi (left), 37, a puff adder bite survivor conducts an education and awareness campaign at a village endemic for high incidents of snake bites on humans in rural Malindi. 'Trauma' In Nairobi, the Snakebite Research and Intervention Centre within the Kenya Institute of Primate Research is working on an antivenom specific to the country and applicable to multiple species. Valentine Musabyimana, a research fellow at the institute, said they "are aiming for an antivenom where a patient will require only one vial with great potency". Government subsidies should make it affordable, she hopes, though it is expected to take about two years before the antivenom is available. That is too late for 14-year-old Shukurani. At the snake farm, Ray warned that the boy faced psychological as well as physical consequences. "Someone has watched their limb completely rot... there's a lot of mental trauma," Ray said. - AFP


Arab Times
26-01-2025
- Arab Times
Some 70 people killed in attack on hospital in Sudan's Darfur region: WHO chief
DUBAI, United Arab Emirates, Jan 26, (AP): Some 70 people were killed in an attack on the only functional hospital in the besieged city of El Fasher in Sudan, the chief of the World Health Organization said Sunday, part of a series of attacks coming as the African nation's civil war escalated in recent days. The attack on the Saudi Teaching Maternal Hospital, which local officials blamed on the rebel Rapid Support Forces, came as the group has seen apparent battlefield losses to the Sudanese military and allied forces under the command of army chief Gen Abdel-Fattah Burhan. That includes Burhan appearing near a burning oil refinery north of Khartoum on Saturday that his forces said they seized from the RSF. Saudi Arabia's Foreign Ministry denounced the attack as "a violation of international law.' International mediation attempts and pressure tactics, including a US assessment that the RSF and its proxies are committing genocide and sanctions targeting Burhan, have not halted the fighting. In the Saudi hospital attack in El Fasher, WHO Director-General Tedros Adhanom Ghebreyesus offered the death toll in a post on the social platform X. Officials and others in the capital of North Darfur province had cited a similar figure Saturday, but Ghebreyesus is the first international source to provide a casualty number. Reporting on Sudan is incredibly difficult given communication challenges and exaggerations by both the RSF and the Sudanese military. "The appalling attack on Saudi Hospital in El Fasher, Sudan, led to 19 injuries and 70 deaths among patients and companions,' Ghebreyesus wrote. "At the time of the attack, the hospital was packed with patients receiving care.' Another health facility in Al Malha also was attacked Saturday, he added. "We continue to call for a cessation of all attacks on health care in Sudan, and to allow full access for the swift restoration of the facilities that have been damaged,' he wrote. "Above all, Sudan's people need peace. The best medicine is peace.' Ghebreyesus did not identify who launched the attack, though local officials had blamed the RSF for the assault. United Nations official Clementine Nkweta-Salami, who coordinates humanitarian efforts for the world body in Sudan, warned Thursday that the RSF earlier had given "a 48-hour ultimatum to forces allied to the Sudanese Armed Forces to vacate the city and indicated a forthcoming offensive.'